Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control.

Pournaras DJ, Glicksman C, Vincent RP, Kuganolipava S, Alaghband-Zadeh J, Mahon D, Bekker JH, Ghatei MA, Bloom SR, Walters JR, Welbourn R, le Roux CW.

Endocrinology. 2012 Aug;153(8):3613-9. doi: 10.1210/en.2011-2145. Epub 2012 Jun 6.

2.

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.

le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, Lönroth H, Fändriks L, Ghatei MA, Bloom SR, Olbers T.

Ann Surg. 2007 Nov;246(5):780-5.

PMID:
17968169
3.

The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study.

Pournaras DJ, Osborne A, Hawkins SC, Mahon D, Ghatei MA, Bloom SR, Welbourn R, le Roux CW.

Obes Surg. 2010 Jan;20(1):56-60. doi: 10.1007/s11695-009-9989-1. Epub 2009 Oct 14.

PMID:
19826888
4.

Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations.

Jørgensen NB, Dirksen C, Bojsen-Møller KN, Kristiansen VB, Wulff BS, Rainteau D, Humbert L, Rehfeld JF, Holst JJ, Madsbad S, Clausen TR.

J Clin Endocrinol Metab. 2015 Mar;100(3):E396-406. doi: 10.1210/jc.2014-1658. Epub 2014 Dec 23.

PMID:
25536209
5.

A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass.

Gerhard GS, Styer AM, Wood GC, Roesch SL, Petrick AT, Gabrielsen J, Strodel WE, Still CD, Argyropoulos G.

Diabetes Care. 2013 Jul;36(7):1859-64. doi: 10.2337/dc12-2255.

6.

Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.

Scholtz S, Miras AD, Chhina N, Prechtl CG, Sleeth ML, Daud NM, Ismail NA, Durighel G, Ahmed AR, Olbers T, Vincent RP, Alaghband-Zadeh J, Ghatei MA, Waldman AD, Frost GS, Bell JD, le Roux CW, Goldstone AP.

Gut. 2014 Jun;63(6):891-902. doi: 10.1136/gutjnl-2013-305008. Epub 2013 Aug 20.

7.

Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass.

Fenske WK, Bueter M, Miras AD, Ghatei MA, Bloom SR, le Roux CW.

Int J Obes (Lond). 2012 Mar;36(3):379-84. doi: 10.1038/ijo.2011.126. Epub 2011 Jun 21.

PMID:
21694700
8.

Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats.

Bhutta HY, Rajpal N, White W, Freudenberg JM, Liu Y, Way J, Rajpal D, Cooper DC, Young A, Tavakkoli A, Chen L.

PLoS One. 2015 Mar 23;10(3):e0122273. doi: 10.1371/journal.pone.0122273. eCollection 2015.

9.

Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.

Kohli R, Bradley D, Setchell KD, Eagon JC, Abumrad N, Klein S.

J Clin Endocrinol Metab. 2013 Apr;98(4):E708-12. doi: 10.1210/jc.2012-3736. Epub 2013 Mar 1.

10.

Short-term glucose metabolism and gut hormone modulations after Billroth II gastrojejunostomy in nonobese gastric cancer patients with type 2 diabetes mellitus, impaired glucose tolerance and normal glucose tolerance.

Zhang XJ, Xiao Z, Yu HL, Zhang XX, Cheng Z, Tian HM.

Arch Med Res. 2013 Aug;44(6):437-43. doi: 10.1016/j.arcmed.2013.07.004. Epub 2013 Aug 22.

PMID:
23973197
11.

Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release.

Rodieux F, Giusti V, D'Alessio DA, Suter M, Tappy L.

Obesity (Silver Spring). 2008 Feb;16(2):298-305. doi: 10.1038/oby.2007.83.

12.

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism.

Patti ME, Houten SM, Bianco AC, Bernier R, Larsen PR, Holst JJ, Badman MK, Maratos-Flier E, Mun EC, Pihlajamaki J, Auwerx J, Goldfine AB.

Obesity (Silver Spring). 2009 Sep;17(9):1671-7. doi: 10.1038/oby.2009.102. Epub 2009 Apr 9.

13.

Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery.

Werling M, Vincent RP, Cross GF, Marschall HU, Fändriks L, Lönroth H, Taylor DR, Alaghband-Zadeh J, Olbers T, Le Roux CW.

Scand J Gastroenterol. 2013 Nov;48(11):1257-64. doi: 10.3109/00365521.2013.833647. Epub 2013 Sep 18.

PMID:
24044585
14.

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.

Dirksen C, Jørgensen NB, Bojsen-Møller KN, Kielgast U, Jacobsen SH, Clausen TR, Worm D, Hartmann B, Rehfeld JF, Damgaard M, Madsen JL, Madsbad S, Holst JJ, Hansen DL.

Int J Obes (Lond). 2013 Nov;37(11):1452-9. doi: 10.1038/ijo.2013.15. Epub 2013 Feb 19.

PMID:
23419600
15.

Effect of bypassing the proximal gut on gut hormones involved with glycemic control and weight loss.

Pournaras DJ, Aasheim ET, Bueter M, Ahmed AR, Welbourn R, Olbers T, le Roux CW.

Surg Obes Relat Dis. 2012 Jul-Aug;8(4):371-4. doi: 10.1016/j.soard.2012.01.021. Epub 2012 Mar 3.

16.

Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass.

Korner J, Inabnet W, Febres G, Conwell IM, McMahon DJ, Salas R, Taveras C, Schrope B, Bessler M.

Int J Obes (Lond). 2009 Jul;33(7):786-95. doi: 10.1038/ijo.2009.79. Epub 2009 May 5.

17.

Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial.

Chronaiou A, Tsoli M, Kehagias I, Leotsinidis M, Kalfarentzos F, Alexandrides TK.

Obes Surg. 2012 Nov;22(11):1761-70. doi: 10.1007/s11695-012-0738-5. Erratum in: Obes Surg. 2013 Mar;23(3):425.

PMID:
22911148
18.

Comparison of the effects of Roux-en-Y gastric bypass and ileal transposition surgeries on food intake, body weight, and circulating peptide YY concentrations in rats.

Chelikani PK, Shah IH, Taqi E, Sigalet DL, Koopmans HH.

Obes Surg. 2010 Sep;20(9):1281-8. doi: 10.1007/s11695-010-0139-6.

PMID:
20386999
19.

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.

le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR.

Ann Surg. 2006 Jan;243(1):108-14.

20.

Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation.

le Roux CW, Borg C, Wallis K, Vincent RP, Bueter M, Goodlad R, Ghatei MA, Patel A, Bloom SR, Aylwin SJ.

Ann Surg. 2010 Jul;252(1):50-6. doi: 10.1097/SLA.0b013e3181d3d21f.

PMID:
20562614
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk